NovAliX Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

NovAliX is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry's outsourcing needs from discovery to manufacturing. With proprietary SPR technology, X-ray protein crystallography, supramolecular mass spectrometry and chemistry, NovAliX offers comprehensive integrated services for small molecule drug discovery. With advanced NMR technologies, NovAliX provides fine characterization of biologics, thorough analysis of APIs and polymor

Company Highlights
Year Founded

2002

icon-altEmployees

377

Location (HQ)

FRA

Since Last Funding

4 years

Monthly Website Visitors

3.0K

icon-altTotal Investment Amt

$2.4M

Last Funding Round

Corporate Round

icon-altMoM Headcount Growth

-0.53%

icon-altYoY Headcount Growth

-0.79%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Pharmaceutical Manufacturing